Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
dJ6CgWmF6E76vXHs
Écouter
Français